Differential expression of Toll-like receptor (TLR) by conventional dendritic cells (cDCs) and plasmacytoid DC (pDCs) has been suggested to influence the type of immune response induced by microbial pathogens. In this study we show that, in vivo, cDCs and pDCs are equally activated by TLR4, -7, and -9 ligands. Type I interferon (IFN) was important for pDC activation in vivo in response to all three TLR ligands, whereas cDCs required type I IFN signaling only for TLR9- and partially for TLR7-mediated activation. Although TLR ligands induced in situ migration of spleen cDC into the T cell area, spleen pDCs formed clusters in the marginal zone and in the outer T cell area 6 h after injection of TLR9 and TLR7 ligands, respectively. In vivo treatment with TLR9 ligands decreased pDC ability to migrate ex vivo in response to IFN-induced CXCR3 ligands and increased their response to CCR7 ligands. Unlike cDCs, the migration pattern of pDCs required type I IFN for induction of CXCR3 ligands and responsiveness to CCR7 ligands. These data demonstrate that mouse pDCs differ from cDCs in the in vivo response to TLR ligands, in terms of pattern and type I IFN requirement for activation and migration.
Skip Nav Destination
Article navigation
4 April 2005
Article|
March 28 2005
Type I interferon dependence of plasmacytoid dendritic cell activation and migration
Carine Asselin-Paturel,
Carine Asselin-Paturel
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Search for other works by this author on:
Géraldine Brizard,
Géraldine Brizard
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Search for other works by this author on:
Karine Chemin,
Karine Chemin
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Search for other works by this author on:
Andre Boonstra,
Andre Boonstra
2Division of Immunoregulation, The National Institute for Medical Research, London NW7 1AA, England, UK
Search for other works by this author on:
Anne O'Garra,
Anne O'Garra
2Division of Immunoregulation, The National Institute for Medical Research, London NW7 1AA, England, UK
Search for other works by this author on:
Alain Vicari,
Alain Vicari
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Search for other works by this author on:
Giorgio Trinchieri
Giorgio Trinchieri
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Search for other works by this author on:
Carine Asselin-Paturel
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Géraldine Brizard
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Karine Chemin
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Andre Boonstra
2Division of Immunoregulation, The National Institute for Medical Research, London NW7 1AA, England, UK
Anne O'Garra
2Division of Immunoregulation, The National Institute for Medical Research, London NW7 1AA, England, UK
Alain Vicari
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
Giorgio Trinchieri
1Laboratory for Immunological Research, Schering-Plough Research Institute, Dardilly 69571, France
CORRESPONDENCE Giorgio Trinchieri: [email protected]
Abbreviations used: cDC, conventional DC; CpG-ODN, oligonucleotides containing CpG motif; DC, dendritic cell; IFNAR−/−, type I IFN receptor deficient; MCMV, murine cytomegalovirus; pDC, plasmacytoid dendritic cell; TLR, Toll-like receptor.
Received:
September 17 2004
Accepted:
February 23 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 201 (7): 1157–1167.
Article history
Received:
September 17 2004
Accepted:
February 23 2005
Citation
Carine Asselin-Paturel, Géraldine Brizard, Karine Chemin, Andre Boonstra, Anne O'Garra, Alain Vicari, Giorgio Trinchieri; Type I interferon dependence of plasmacytoid dendritic cell activation and migration . J Exp Med 4 April 2005; 201 (7): 1157–1167. doi: https://doi.org/10.1084/jem.20041930
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement